StockUnited StatesNasdaqGS

MRNA

Moderna, Inc.

Healthcare · Biotechnology

200.10USD

-2.5300 (-1.25%)

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out

Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
A take fades: it counts half as much after 7 days and drops out after 30.
Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
Your own take is private: only the totals are shown, and never who said what.

Description Historical Financials Relative Value Research News Community Room OptionsPrice Chart ↗Fundamental Chart ↗

Valuation

P/E (TTM)

—

P/E (Forward)

—

EV/EBITDA

—

EV/Revenue

34.13x

P/S (TTM)

35.86x

P/B

11.82x

FCF Yield

-1.56%

Dividend Yield

0.00%

Gross Margin

23.38%

Operating Margin

-149.01%

Net Margin

-141.43%

Peer Comparison — Biotechnology

Company	Mkt Cap	P/E	EV/EBITDA	FCF Yield	Rev Growth	Div Yield
MRNAModerna, Inc.	$79.89B	—	—	-1.56%	2.11%	0.00%
VRTXVertex Pharmaceuticals Incorporated	$132.71B	30.51x	24.88x	1.98%	12.50%	0.00%

Subject metrics from SEC filings where available; peer metrics from cached market data.

Computing valuation metrics…